Main Information
The pharmacokinetic profile of ramipril was studied in 30 paediatric hypertensive patients, aged 2-16 years, weighing ≥ 10kg
RAVIMI OMADUSTE KOKKUVÕTE
3, 4
Ramipril should be started gradually with an initial recommended dose of 2
5 and 5
Below is a text only representation of the Patient Information Leaflet (ePIL)
4, 4
ALTACE® Tablets (ramipril) are a brand name of ramipril, a drug that lowers blood pressure by inhibiting the renin-angiotensin-aldosterone system
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor and is utilized for multiple indications, including hypertension and prevention of heart failure progression following a myocardial infarction (MI)
Dosage
UKPAR Ramipril 1
Medicine PIL SPC XPIL Legal Category Active Ingredient(s) Company
Group Information
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet
Apply
4